Insider · CIK 0001767321
Matthew R Henn
Files at MCRB (Seres Therapeutics, Inc.). First filing Oct 29, 2024, latest May 19, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MCRB: Seres Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | Seres Therapeutics, Inc. | $561 77 shares | -2% | +10% from low-68% from high | |
| 0Weak | Seres Therapeutics, Inc. | $3,204 3,953 shares | -4% | - | |
| 0Weak | Seres Therapeutics, Inc. | $501 927 shares | -1% | - | |
| 0Weak | Seres Therapeutics, Inc. | $2,749 3,984 shares | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | MCRB Seres Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +140 | - | - | 4,362 | May 19, 2025 |
| May 15, 2025 | MCRB Seres Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +98 | - | - | 4,460 | May 19, 2025 |
| May 16, 2025 | MCRB Seres Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -77 | $7.28 | $561 | 4,383 | May 19, 2025 |
| May 15, 2025 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -140 | $0.00 | $0 | 985 | May 19, 2025 |
| May 15, 2025 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -98 | $0.00 | $0 | 1,073 | May 19, 2025 |
| Feb 15, 2025 | MCRB Seres Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,813 | - | - | 80,583 | Feb 19, 2025 |
| Feb 15, 2025 | MCRB Seres Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +7,813 | - | - | 88,396 | Feb 19, 2025 |
| Feb 18, 2025 | MCRB Seres Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,953 | $0.81 | $3,204 | 84,443 | Feb 19, 2025 |
| Feb 15, 2025 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -2,813 | $0.00 | $0 | 22,500 | Feb 19, 2025 |
| Feb 15, 2025 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -7,813 | $0.00 | $0 | 23,437 | Feb 19, 2025 |
| Feb 7, 2025 | MCRB Seres Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +650,000 | $0.00 | $0 | 650,000 | Feb 11, 2025 |
| Nov 15, 2024 | MCRB Seres Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +2,812 | - | - | 78,697 | Nov 19, 2024 |
| Nov 18, 2024 | MCRB Seres Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -927 | $0.54 | $501 | 77,770 | Nov 19, 2024 |
| Nov 15, 2024 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -2,812 | $0.00 | $0 | 25,313 | Nov 19, 2024 |
| Oct 27, 2024 | MCRB Seres Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +12,622 | $0.00 | $0 | 79,869 | Oct 29, 2024 |
| Oct 28, 2024 | MCRB Seres Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,984 | $0.69 | $2,749 | 75,885 | Oct 29, 2024 |
| Oct 27, 2024 | MCRB Seres Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -12,622 | $0.00 | $0 | 0 | Oct 29, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.